Compare Amylx Pharmaceuticals Inc (AMLX) vs iShares 0 3 Month Treasury Bond ETF (SGOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs iShares 0 3 Month Treasury Bond ETF — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while iShares 0 3 Month Treasury Bond ETF trades at $100.52. The key difference: Amylx Pharmaceuticals Inc is trading nearer its 52-week high, iShares 0 3 Month Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| AMLX | SGOV | |
|---|---|---|
Market Cap | $2.64B | — |
Sector | Health | Fixed Income |
52-Week High | $24.19 | $100.74 |
52-Week Low | $7.82 | $100.28 |
Enterprise Value | $2.39B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About iShares 0 3 Month Treasury Bond ETF
SGOV provides exposure to ultra-short-term U.S. Treasury bills with maturities of three months or less. It functions as a high-liquidity cash alternative, seeking to provide current income while maintaining a stable net asset value and minimal interest rate risk.
Read more on SGOV →
